iBio, Inc.IBIONYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+155.3%
5Y CAGR-25.1%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+155.3%/yr
vs -51.4%/yr prior
5Y CAGR
-25.1%/yr
Recent acceleration
Acceleration
+206.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 20.03 | -41.5% |
| 2024 | 34.22 | - |
| 2023 | 0.00 | -100.0% |
| 2022 | 1.20 | -99.0% |
| 2021 | 124.58 | +46.4% |
| 2020 | 85.11 | +1196.4% |
| 2019 | 6.57 | -69.5% |
| 2018 | 21.55 | -75.6% |
| 2017 | 88.21 | +43.4% |
| 2016 | 61.50 | - |